Associations between atherosclerosis and neurological diseases, beyond ischemia-induced cerebral damage

Rev Endocr Metab Disord. 2019 Mar;20(1):15-25. doi: 10.1007/s11154-019-09486-z.

Abstract

Neurodegeneration is traditionally viewed as a consequence of peptide accumulation in the brain, stroke and/or cerebral ischemia. Nonetheless, a number of scattered observations suggest that neurological disease and atherosclerosis may be linked by more complex mechanisms. Understanding the intricate link between atherosclerosis and neurological conditions may have a significant impact on the quality of life of the growing ageing population and of high cardiovascular risk groups in general. Epidemiological data support the notion that neurological dysfunction and atherosclerosis coexist long before any evident clinical complications of cardiovascular disease appear and may be causally linked. Baffling, often overlooked, molecular data suggest that nervous tissue-specific gene expression is relaxed specifically in the atheromatous vascular wall, and/or that a systemic dysregulation of genes involved in nervous system biology dictates a concomitant progression of neurological disease and atherosclerosis. Further epidemiological and experimental work is needed to clarify the details and clinical relevance of those complex links.

Keywords: Atherosclerosis; Endothelial dysfunction; Gene expression; Ischemia; Neurodegeneration.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Atherosclerosis / physiopathology*
  • Brain Ischemia / physiopathology*
  • Humans
  • Neurodegenerative Diseases / physiopathology*
  • Quality of Life
  • Stroke / physiopathology*